# Effect of Erythropoietin on Preterm Brain Injury

> **NCT02036073** · PHASE4 · COMPLETED · sponsor: **Zhengzhou Children's Hospital, China** · enrollment: 490 (actual)

## Conditions studied

- Premature Birth

## Interventions

- **DRUG:** recombinant human erythropoietin

## Key facts

- **NCT ID:** NCT02036073
- **Lead sponsor:** Zhengzhou Children's Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2012-06
- **Final completion:** 2013-12
- **Target enrollment:** 490 (ACTUAL)
- **Last updated:** 2014-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02036073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02036073, "Effect of Erythropoietin on Preterm Brain Injury". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02036073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*